These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 37078466)
21. Lysosomal protein thermal stability does not correlate with cellular half-life: global observations and a case study of tripeptidyl-peptidase 1. Collier AM; Nemtsova Y; Kuber N; Banach-Petrosky W; Modak A; Sleat DE; Nanda V; Lobel P Biochem J; 2020 Feb; 477(3):727-745. PubMed ID: 31957806 [TBL] [Abstract][Full Text] [Related]
22. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis. Drack AV; Miller JN; Pearce DA J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479 [TBL] [Abstract][Full Text] [Related]
23. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype. Xiong J; Kielian T J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525 [TBL] [Abstract][Full Text] [Related]
24. Alterations in ROS activity and lysosomal pH account for distinct patterns of macroautophagy in LINCL and JNCL fibroblasts. Vidal-Donet JM; Cárcel-Trullols J; Casanova B; Aguado C; Knecht E PLoS One; 2013; 8(2):e55526. PubMed ID: 23408996 [TBL] [Abstract][Full Text] [Related]
25. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. Teixeira C; Guimarães A; Bessa C; Ferreira MJ; Lopes L; Pinto E; Pinto R; Boustany RM; Sá Miranda MC; Ribeiro MG J Neurol; 2003 Jun; 250(6):661-7. PubMed ID: 12796825 [TBL] [Abstract][Full Text] [Related]
27. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function. Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248 [TBL] [Abstract][Full Text] [Related]
28. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis]. Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038 [TBL] [Abstract][Full Text] [Related]
29. Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis. Chang M; Cooper JD; Sleat DE; Cheng SH; Dodge JC; Passini MA; Lobel P; Davidson BL Mol Ther; 2008 Apr; 16(4):649-56. PubMed ID: 18362923 [TBL] [Abstract][Full Text] [Related]
30. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3). Burkovetskaya M; Karpuk N; Kielian T Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098 [TBL] [Abstract][Full Text] [Related]
31. Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis. Xu S; Wang L; El-Banna M; Sohar I; Sleat DE; Lobel P Mol Ther; 2011 Oct; 19(10):1842-8. PubMed ID: 21730969 [TBL] [Abstract][Full Text] [Related]
32. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis. Oetjen S; Kuhl D; Hermey G J Neurochem; 2016 Nov; 139(3):456-470. PubMed ID: 27453211 [TBL] [Abstract][Full Text] [Related]
33. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage. Dannhausen K; Möhle C; Langmann T Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155 [TBL] [Abstract][Full Text] [Related]
34. Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis. Guhaniyogi J; Sohar I; Das K; Stock AM; Lobel P J Biol Chem; 2009 Feb; 284(6):3985-97. PubMed ID: 19038967 [TBL] [Abstract][Full Text] [Related]
35. Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis. Nemtsova Y; Wiseman JA; El-Banna M; Lobel P; Sleat DE PLoS One; 2018; 13(2):e0192286. PubMed ID: 29408933 [TBL] [Abstract][Full Text] [Related]
36. Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis. Weimer JM; Benedict JW; Getty AL; Pontikis CC; Lim MJ; Cooper JD; Pearce DA Brain Res; 2009 Apr; 1266():93-107. PubMed ID: 19230832 [TBL] [Abstract][Full Text] [Related]
37. Cln3 function is linked to osmoregulation in a Dictyostelium model of Batten disease. Mathavarajah S; McLaren MD; Huber RJ Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3559-3573. PubMed ID: 30251676 [TBL] [Abstract][Full Text] [Related]
38. Atypical late infantile and juvenile forms of neuronal ceroid lipofuscinosis and their diagnostic difficulties. Wiśniewski KE; Zhong N; Kida E; Kaczmarski W; Kaczmarski A; Connell F; Brooks SS; Brown WT Folia Neuropathol; 1997; 35(2):73-9. PubMed ID: 9377079 [TBL] [Abstract][Full Text] [Related]
39. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective. Kühl TG; Dihanich S; Wong AM; Cooper JD J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506 [TBL] [Abstract][Full Text] [Related]
40. TPP1 Delivery to Lysosomes with Extracellular Vesicles and their Enhanced Brain Distribution in the Animal Model of Batten Disease. Haney MJ; Klyachko NL; Harrison EB; Zhao Y; Kabanov AV; Batrakova EV Adv Healthc Mater; 2019 Jun; 8(11):e1801271. PubMed ID: 30997751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]